PD-Rx Pharmaceuticals recalls

3 official recalls and safety alerts involving PD-Rx Pharmaceuticals since 2022-07, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with PD-Rx Pharmaceuticals or the relevant agency.

1. 2025-01-01
2. US
   Drugs & medicalClass II

   PD-Rx Pharmaceuticals, Inc. recalls DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90

   CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit

   FDA · DrugPD-Rx Pharmaceuticals, Inc.Distributed within US: FL, MS, WIOfficial notice →
3. 2023-05-10
4. US
   Drugs & medicalClass II

   PD-Rx Pharmaceuticals, Inc. recalls Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK…

   CGMP deviations.

   FDA · DrugPD-Rx Pharmaceuticals, Inc.Nationwide in the US.Official notice →
5. 2022-07-06
6. US
   Drugs & medicalClass II

   PD-Rx Pharmaceuticals, Inc. recalls Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx Pharmaceuticals, Inc. Oklahoma…

   CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

   FDA · DrugPD-Rx Pharmaceuticals, Inc.NationwideOfficial notice →